U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06834295) titled 'A Study to Evaluate Metabolism, Excretion, and Mass Balance of [14C]Vapendavir' on Feb. 11.
Brief Summary: The goal of this clinical trial is to assess how the body processes, breaks down and removes a new test medicine (vapendavir) from the body in healthy male participants.The main question it aims to answer is how the body handles the test medicine. In order to do that, the test medicine will be radiolabeled to track the test medicine in the body.
Healthy male participants who meet entry criteria will be admitted to the clinic for a duration of approximately 9 days (Day -1 to Day 8). Participants will be admitted in the evening ...